A9607 HCPCS code: Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie
A9607 is the HCPCS Level II code for lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie. In 2024 Medicare paid an average of $203.56 per service for A9607 across 637,367 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 216 per day on outpatient hospital claims. Medicare volume rose 412% from 2022 to 2024 (124,556 to 637,367 services). In 2024, about 265 clinicians billed Medicare for A9607 for 1,073 beneficiaries; Arizona, Florida, Texas accounted for 35% of services.
Code details
| Field | Value |
|---|---|
| Section | A codes — Transportation, medical/surgical supplies and miscellaneous |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 57 |
| BETOS category | I1E |
| Added | 2022-10-01 |
| Last action effective | 2025-01-01 |
Who bills A9607 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 265 |
| Medicare beneficiaries | 1,073 |
| States with claims | 25 |
| Share of services in top 3 states (Arizona, Florida, Texas) | 35% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for A9607, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 124,556 | 386 | $244.61 | $194.89 |
| 2023 | 592,041 | 1,019 | $248.45 | $197.94 |
| 2024 | 637,367 | 1,073 | $255.49 | $203.56 |
States with the most A9607 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Arizona | 91,106 | $203.76 |
| Florida | 70,463 | $200.59 |
| Texas | 57,950 | $210.48 |
| Maryland | 46,628 | $207.20 |
| Virginia | 42,753 | $204.83 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 216 | Prescribing Information |
| practitioner claims | 216 | Prescribing Information |
What changed for A9607
- 2022-10-01: A9607 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code A9607?
A9607 is the HCPCS Level II code for lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie. Short descriptor: "Lutetium lu 177 vipivotide".
How much does Medicare pay for A9607?
In 2024, the average Medicare payment was $203.56 per service (average allowed $255.49).
Does Medicare cover A9607?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of A9607 can be billed per day?
216 on outpatient hospital claims; 216 on practitioner claims (NCCI medically unlikely edits).
Related A96 codes
- A9600 — Strontium sr-89 chloride, therapeutic, per millicurie
- A9601 — Flortaucipir f 18 injection, diagnostic, 1 millicurie
- A9602 — Fluorodopa f-18, diagnostic, per millicurie
- A9603 — Injection, pafolacianine, 0.1 mg
- A9604 — Samarium sm-153 lexidronam, therapeutic, per treatment dose, up to 150 millicuries
- A9606 — Radium ra-223 dichloride, therapeutic, per microcurie
- A9608 — Flotufolastat f 18, diagnostic, 1 millicurie
- A9609 — Fludeoxyglucose f18 up to 15 millicuries
- A9610 — Xenon xe-129 hyperpolarized gas, diagnostic, per study dose
- A9611 — Flurpiridaz f 18, diagnostic, 1 millicurie
- A9612 — Injection, fluorescein, 1 mg
- A9613 — Piflufolastat f 18 (pylarify truvu), diagnostic, 1 millicurie
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under A9607
- Watch A9607 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for A9607
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.